19 December 2025 - Recommendations made by the PBAC in November 2025 relating to the listing of medicines on the ...
18 December 2025 - The final PBAC update for 2025 is now available. ...
12 December 2025 - Patients are spending as much as $5,000/year on private market GLP-1 therapies – an incoming PBAC recommendation ...
5 December 2025 - The agenda for the December 2025 PBAC meeting is now available. ...
19 November 2025 - The agenda for the March 2026 PBAC meeting is now available. ...
14 November 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the July 2025 PBAC ...
31 October 2025 - The DoH has published a revised agenda for the November 2025 PBAC meeting. ...
31 October 2025 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the July 2025 PBAC ...
17 October 2025 - Two common immunotherapy drugs will now be subsidised for all advanced or metastatic cancers, providing a ...
17 October 2025 - More Australians living with advanced cancer could have access to immunotherapy treatment options, thanks to a ...
17 October 2025 - Recommendations made by the PBAC in September 2025 relating to the listing of medicines on the PBS ...
30 September 2025 - Health technology assessment has been characterised as a complex adaptive system that centrally features stakeholder interactions. ...
12 September 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the May 2025 PBAC ...
5 September 2025 - The DoH has published a revised agenda for the November 2025 PBAC meeting. ...
2 September 2025 - The agenda for the September 2025 PBAC meeting has now been updated. ...